No Cover Image

Journal article 646 views 117 downloads

Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial

Lawrence A. Leiter, Stephen C. Bain, Irene Hramiak, Esteban Jódar, Sten Madsbad, Theis Gondolf, Thomas Hansen, Ingrid Holst, Ildiko Lingvay, Steve Bain Orcid Logo

Cardiovascular Diabetology, Volume: 18, Issue: 1

Swansea University Author: Steve Bain Orcid Logo

  • 50453.pdf

    PDF | Version of Record

    Released under the terms of a Creative Commons Attribution 4.0 International License (CC-BY).

    Download (1.21MB)
Published in: Cardiovascular Diabetology
ISSN: 1475-2840
Published: 2019
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa50453
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2019-05-20T11:26:45Z
last_indexed 2019-06-19T20:51:27Z
id cronfa50453
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2019-06-19T10:09:22.3350512</datestamp><bib-version>v2</bib-version><id>50453</id><entry>2019-05-20</entry><title>Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2019-05-20</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Cardiovascular Diabetology</journal><volume>18</volume><journalNumber>1</journalNumber><publisher/><issnElectronic>1475-2840</issnElectronic><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2019</publishedYear><publishedDate>2019-12-31</publishedDate><doi>10.1186/s12933-019-0871-8</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2019-06-19T10:09:22.3350512</lastEdited><Created>2019-05-20T09:44:36.6097731</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Lawrence A.</firstname><surname>Leiter</surname><order>1</order></author><author><firstname>Stephen C.</firstname><surname>Bain</surname><order>2</order></author><author><firstname>Irene</firstname><surname>Hramiak</surname><order>3</order></author><author><firstname>Esteban</firstname><surname>J&#xF3;dar</surname><order>4</order></author><author><firstname>Sten</firstname><surname>Madsbad</surname><order>5</order></author><author><firstname>Theis</firstname><surname>Gondolf</surname><order>6</order></author><author><firstname>Thomas</firstname><surname>Hansen</surname><order>7</order></author><author><firstname>Ingrid</firstname><surname>Holst</surname><order>8</order></author><author><firstname>Ildiko</firstname><surname>Lingvay</surname><order>9</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>10</order></author></authors><documents><document><filename>0050453-19062019100837.pdf</filename><originalFilename>50453.pdf</originalFilename><uploaded>2019-06-19T10:08:37.4070000</uploaded><type>Output</type><contentLength>1316139</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><embargoDate>2019-06-18T00:00:00.0000000</embargoDate><documentNotes>Released under the terms of a Creative Commons Attribution 4.0 International License (CC-BY).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807>
spelling 2019-06-19T10:09:22.3350512 v2 50453 2019-05-20 Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2019-05-20 BMS Journal Article Cardiovascular Diabetology 18 1 1475-2840 31 12 2019 2019-12-31 10.1186/s12933-019-0871-8 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2019-06-19T10:09:22.3350512 2019-05-20T09:44:36.6097731 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Lawrence A. Leiter 1 Stephen C. Bain 2 Irene Hramiak 3 Esteban Jódar 4 Sten Madsbad 5 Theis Gondolf 6 Thomas Hansen 7 Ingrid Holst 8 Ildiko Lingvay 9 Steve Bain 0000-0001-8519-4964 10 0050453-19062019100837.pdf 50453.pdf 2019-06-19T10:08:37.4070000 Output 1316139 application/pdf Version of Record true 2019-06-18T00:00:00.0000000 Released under the terms of a Creative Commons Attribution 4.0 International License (CC-BY). true eng
title Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
spellingShingle Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
Steve Bain
title_short Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
title_full Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
title_fullStr Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
title_full_unstemmed Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
title_sort Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
author_id_str_mv 5399f4c6e6a70f3608a084ddb938511a
author_id_fullname_str_mv 5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain
author Steve Bain
author2 Lawrence A. Leiter
Stephen C. Bain
Irene Hramiak
Esteban Jódar
Sten Madsbad
Theis Gondolf
Thomas Hansen
Ingrid Holst
Ildiko Lingvay
Steve Bain
format Journal article
container_title Cardiovascular Diabetology
container_volume 18
container_issue 1
publishDate 2019
institution Swansea University
issn 1475-2840
doi_str_mv 10.1186/s12933-019-0871-8
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2019-12-31T04:01:55Z
_version_ 1763753187468115968
score 11.011422